About this white paper
Key topics covered in this resource
For DTx solutions to be integrated into mainstream healthcare, they must secure health authority (HA) approval. In certain scenarios, if the solution offers considerable societal benefits, HAs might even permit DTx to be prescribed by healthcare professionals and, depending on the country, offer reimbursement.
This whitepaper will help you navigate the intricate maze of the current DTx regulatory environment, highlighting several important countries and regulations.
